Clinical trials in Fulda – page 2

37 clinical trials in Fulda, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in GermanyKlinischeStudien.de

Fulda at a glance

clinical trials

Paediatric trials0
Research sites2

Quick filters

37 trials in Fulda

Open in trial search

Acute lymphocytic leukaemia

Recruiting

Study on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo

Study on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo

Germany

Participants:18–64 years
Substances:Blinatumomab
Sponsor:Goethe University Frankfurt

Contact Research Centre

Crohn's disease

Recruiting

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:ABBV-8736
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Chronic kidney disease

Not yet recruiting

Phase III Randomized Study of Balcinrenone and Dapagliflozin Versus Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease Stage 3b‑4

Registered drug

Phase III Randomized Study of Balcinrenone and Dapagliflozin Versus Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease Stage 3b‑4

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Balcinrenone
Sponsor:AstraZeneca AB

Contact Research Centre

Obesity+1

Not yet recruiting

Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes

Investigational

Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes

Investigational

Germany

Participants:18–64 years · 65+ years
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Type 2 diabetes mellitus+2

Not yet recruiting

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational

Germany

Participants:18–64 years · 65+ years
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Pharyngitis

Not yet recruiting

Study of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms

Registered drug

Study of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:2,4 dichlorobenzyl alcohol
Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG

Contact Research Centre

Type 2 diabetes mellitus

Not yet recruiting

Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

Registered drugNo placebo

Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Insulin degludec
Sponsor:Novo Nordisk A/S

Contact Research Centre

Hypercholesterolaemia

Not recruiting

Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

Investigational

Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Laroprovstat
Sponsor:AstraZeneca AB

Contact Research Centre

Cardiac failure

Not recruiting

Evaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

Investigational

Evaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Ziltivekimab
Sponsor:Novo Nordisk A/S

Contact Research Centre

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Evolocumab
Sponsor:Amgen Inc.

Contact Research Centre

Colitis ulcerative

Not recruiting

Study on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis

Investigational

Study on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Eclitasertib
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Type 2 diabetes mellitus

Not recruiting

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo

Evaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Dulaglutide
Sponsor:Eli Lilly & Co.

Contact Research Centre

Other cities in Germany

The busiest research cities in the country

All 518 cities in Germany

Clinical research in Fulda

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on heart failure prevention and management of cardiovascular risks, including evaluation of new combination therapies to reduce cardiac events.

Heart Failure Prevention
Stroke Management
Cardiovascular Risk Reduction

Groundbreaking research includes assessment of treatments for acute ischemic stroke and high-risk transient ischemic attacks.

02 Metabolic Disorders

Comprehensive research into type 2 diabetes and obesity management, evaluating innovative treatments for weight reduction and metabolic control.

Weight Management Studies
Diabetes Treatment
Metabolic Health

Studies focus on both standalone conditions and cases where obesity and diabetes coexist.

03 Oncology Studies

Advanced research in cancer treatment, particularly focusing on ovarian cancer and colon cancer therapeutic approaches.

Ovarian Cancer Therapy
Colon Cancer Treatment
Hodgkin Lymphoma Management

Investigations include targeted therapies and novel treatment combinations for various cancer stages.

04 Gastrointestinal Research

Studies examining digestive disorders and innovative treatments for various gastrointestinal conditions.

Ulcerative Colitis
Irritable Bowel Syndrome
Microbiome Studies

Research includes microbiota transplantation and novel therapeutic approaches for chronic conditions.

05 Respiratory Medicine

Focused research on pulmonary conditions, particularly investigating treatments for idiopathic pulmonary fibrosis.

Lung Function Improvement
Pulmonary Fibrosis
Respiratory Health

Studies aim to enhance lung function and improve treatment outcomes in chronic respiratory conditions.

Back to Germany All countries